InicioSAN • EPA
add
Sanofi
Cierre anterior
87,47 €
Intervalo diario
87,17 € - 88,44 €
Intervalo anual
76,78 € - 110,88 €
Cap. bursátil
106,89 mil M EUR
Volumen medio
1,75 M
Relación precio-beneficio
11,89
Rentabilidad por dividendo
-
Bolsa de valores principal
EPA
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (EUR) | jun 2025info | Cambio interanual |
|---|---|---|
Ingresos | 10,74 mil M | -0,09 % |
Gastos operativos | 5811,00 M | — |
Ingresos netos | 3940,00 M | — |
Margen de beneficio neto | 36,70 | — |
Beneficios por acción | 0,91 | -47,43 % |
EBITDA | 2690,50 M | — |
Tipo impositivo efectivo | 15,68 % | — |
Balance general
Activos totales
Responsabilidades totales
| (EUR) | jun 2025info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 15,36 mil M | 126,03 % |
Activos totales | 124,96 mil M | -3,70 % |
Responsabilidades totales | 54,68 mil M | -3,66 % |
Patrimonio total | 70,28 mil M | — |
Acciones en circulación | 1217,10 M | — |
Precio-valor contable | 1,52 | — |
Rentabilidad económica | — | — |
Retorno sobre capital | 5,13 % | — |
Flujo de caja
Variación neta del flujo de caja
| (EUR) | jun 2025info | Cambio interanual |
|---|---|---|
Ingresos netos | 3940,00 M | — |
Efectivo de operaciones | — | — |
Efectivo de inversión | — | — |
Efectivo de financiación | — | — |
Variación neta del flujo de caja | — | — |
Flujo de caja libre | — | — |
Información sobre la empresa
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Director ejecutivo
Fundación
1973
Sitio web
Empleados
82.878
